| |
| |
|
| Insider
Information: |
Pyott David E I |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
117,432 |
|
|
Indirect Shares
|
27,900 |
|
|
| Direct
Value |
$9,679,774 |
|
|
|
Indirect Value
|
$3,998,349 |
|
|
| Total
Shares |
145,332 |
|
|
| Total
Value |
$13,678,123 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 128.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avery Dennison Corporation |
AVY |
Director |
2020-04-23 |
18,684 |
2004-04-22 |
0 |
Premium* |
|
|
Edwards Lifesciences Corp |
EW |
Director |
2014-05-09 |
53,582 |
2004-05-13 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2023-05-23 |
45,030 |
2016-01-04 |
0 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2023-02-23 |
136 |
2023-02-23 |
27,900 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,190 |
45,030 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2023-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
136 |
136 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,980 |
40,840 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,120 |
35,860 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2020-08-31 |
4 |
B |
$78.22 |
$1,001,715 |
D/D |
12,800 |
30,740 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
17,940 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2020-04-23 |
4 |
OE |
$107.56 |
$152,090 |
D/D |
1,414 |
18,684 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2020-02-03 |
4 |
S |
$132.72 |
$667,183 |
D/D |
(5,027) |
17,270 |
0 |
% |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2020-02-03 |
4 |
OE |
$38.18 |
$191,931 |
D/D |
5,027 |
22,297 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,430 |
13,640 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2019-05-01 |
4 |
OE |
$109.63 |
$216,739 |
D/D |
1,977 |
17,270 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2018-11-27 |
4 |
S |
$93.00 |
$186,000 |
D/D |
(2,000) |
15,293 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2018-11-27 |
4 |
OE |
$20.64 |
$41,280 |
D/D |
2,000 |
17,293 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2018-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
9,210 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2018-05-01 |
4 |
OE |
$104.80 |
$321,317 |
D/D |
3,066 |
15,293 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2017-08-30 |
4 |
S |
$94.00 |
$159,988 |
D/D |
(1,702) |
16,303 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2017-08-30 |
4 |
OE |
$52.12 |
$88,700 |
D/D |
1,702 |
18,005 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2017-08-28 |
4 |
S |
$94.00 |
$28,012 |
D/D |
(298) |
16,303 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2017-08-28 |
4 |
OE |
$52.12 |
$15,530 |
D/D |
298 |
16,601 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2017-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,050 |
4,910 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2017-05-01 |
4 |
OE |
$83.42 |
$187,278 |
D/D |
2,245 |
16,303 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2016-10-13 |
4 |
B |
$37.00 |
$1,032,328 |
I/I |
27,900 |
27,900 |
2.1 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2016-08-08 |
4 |
S |
$78.61 |
$157,220 |
D/D |
(2,000) |
14,058 |
0 |
- |
|
| AVY |
Avery Dennison Corporatio... |
Director |
• • – |
2016-08-08 |
4 |
OE |
$67.80 |
$135,590 |
D/D |
2,000 |
16,058 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2016-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
760 |
2,860 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
